MoonLake Immunotherapeutics and uniQure Announce $150M Public Offerings

MoonLake Immunotherapeutics and uniQure have both announced proposed public offerings of ordinary shares, each aiming to raise $150 million. These offerings are intended to secure significant capital for their respective companies.